Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06410651
Status:
RECRUITING
Last Update Posted:
2024-05-13
First Post:
2024-05-05
Brief Title:
Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma
Sponsor:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Organization:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Esophageal Cancer |
| Nimotuzumab |
| Chemoradiotherapy |
| Chemotherapy |
| Immunotherapy |
Keywords: